Elevated infection levels stoked concerns that more lockdown measures may be looming, potentially dealing another blow to the economic recovery.
Tom BurtonU.S. stocks fell, suggesting selloff may pick up pace, as rising coronavirus infections shook investors’ confidence. It has always seemed clear that it was necessary to get Covid rates really low before the economy could permanently recover. wsj.com/articles/globa… via @WSJ
FDA officials gave fresh assurances that Covid-19 vaccines will undergo rigorous testing before being made widely available, during a meeting with outside medical experts aimed at bolstering the agency’s credibility.
Tom BurtonFDA promises strong vaccine safety standards in panel hearing. Very smart discussion; concerns raised about whether 2 months for safety monitoring is enough, and whether studies should include more serious-disease cases.
wsj.com/articles/fda-p… via @WSJ
Health authorities, hospitals and pharmaceutical companies plan to use fake shipments, GPS trackers and other steps to protect the shots against potential thefts.
Tom BurtonFake shipments in dummy trucks. Black-light verification on vials. Drugmakers and health authorities are trying to protect Covid-19 vaccines against theft. “We are appropriately paranoid.” wsj.com/articles/covid… via @WSJ
U.K. researchers plan to start infecting healthy volunteers with tightly controlled doses of the coronavirus in what they called a first-of-its-kind effort to more rapidly gauge the effectiveness of multiple vaccines.
Tom BurtonResearchers plan to start infecting healthy volunteers in UK with the coronavirus. In the middle of a global Covid epidemic, the UK doctors couldn't find a way to test vaccines without intentionally exposing people to the virus? wsj.com/articles/volun… via @WSJ
The suspension of Johnson & Johnson’s trials poses another setback for global efforts to develop a shot to protect lives and jump-start economies battered by the pandemic, as well as a reminder of the challenges of fast-tracking vaccine development.
Tom BurtonThe pause in another of the West’s most advanced Covid studies is a setback, but shows how carefully vaccine companies and regulators are being -- in contrast to the US president.
wsj.com/articles/j-j-v… via @WSJ
The U.S. reported more than 58,000 new coronavirus infections, continuing an upward trend in recent days, as the national death toll exceeded 220,000.
Tom BurtonCovid-19 cases surge again in US -- new U.S. infections topped 58,000 Monday -- but Trump denounces "Fauci and all these idiots" who urge strict measures to battle virus.
wsj.com/articles/coron… via @WSJ
A surge in coronavirus infections is forcing U.S. states and European countries to shut down bars, open field hospitals and limit social gatherings, but in much of Asia, such measures are becoming distant memories.
Tom BurtonCoronavirus cases surge again in Europe and U.S., but Asia is back to near normal by being realistically stringent and driving infection rates way down. wsj.com/articles/covid… via @WSJ
Moderna Chief Executive Stéphane Bancel said the federal government could authorize emergency use of the company’s experimental Covid-19 vaccine in December, if the company gets positive interim results in November from a large clinical trial.
One reason many Northeastern colleges have experienced few coronavirus outbreaks has been a testing operation run by Broad Institute of MIT and Harvard with 14-hour turnaround times and low-cost tests.
Tom BurtonTesting, Testing: It helped many colleges avoid large coronavirus outbreaks. Major side note: Masks, distancing, hand-washing, etc., still vital. wsj.com/articles/how-a… via @WSJ
Drug giant Pfizer said it could be ready to apply for emergency-use authorization of its Covid-19 vaccine by late November, assuming it receives positive efficacy and safety data from late-stage human trials.
While the U.S. and Europe await the results of large-scale clinical trials before deploying coronavirus vaccines, some other nations are moving much faster with emergency-use rollouts of experimental Chinese and Russian candidates.
Tom BurtonThe United Arab Emirates is inoculating medical workers, teachers and airport staff with a Chinese shot. Paucity of effectiveness, safety data so far. Will this be like the catfood from China that killed cats? wsj.com/articles/russi… via @WSJ
Johnson & Johnson hopes to know within days whether it can resume testing its Covid-19 vaccine, although executives said they know little about the illness that prompted a pause in the clinical trials.
Tom BurtonJohnson & Johnson’s Covid-19 vaccine trial could resume soon, the firm said, but first outside researchers have to learn what made a volunteer ill wsj.com/articles/j-j-h… via @WSJ
President Trump’s endorsement of an experimental Covid-19 drug from Regeneron Pharmaceuticals has raised expectations for a type of medicine that could be authorized for public use within weeks or even days.
Tom BurtonAfter President Trump sang the praises of a Covid-19 antibody drug he took, the FDA is evaluating two antibody drugs from Regeneron and Lilly. Trump once again puts pressure on the agency to act quickly. wsj.com/articles/antib… via @WSJ
The White House endorsed the Food and Drug Administration’s plans for assessing whether a Covid-19 vaccine should be given widely, casting aside objections to requirements that would likely mean a shot won’t be cleared until after Election Day,...
Tom BurtonWhite House officials denied they had ever opposed the new #FDA guidelines on vaccin standards. Then last night Trump tweeted that the plans were "just another political hit job." wsj.com/articles/white… via @WSJ